There was an announcement made recently that Thomas Jefferson University would be working in conjunction with a company called NuView Radiopharmaceuticals to develop a new type of PET scan imaging. The two organizations came to an agreement about the development and distribution of the product which is designed to improve imaging for both breast and prostate cancers.
The new PET imaging, which will be further developed by the university through funding provided by the company, is believed to have the potential to improve multiple areas of the medical approach to treating these cancers. For one thing, it is believed to allow for earlier diagnosis which leads to disease prevention. And for another, it is hopeful that this imaging will assist in the monitoring of treatment to improve the medical care given to these patients.
Question of the Day: What role do you think companies like this should play in supporting medical research at universities?
